Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Mechanism of TNF-alpha production in tumor tissues by Ono-4007

Jan. 5, 1998

Favorable phase III trial results reported for HER2 monoclonal antibody

Dec. 31, 1997

Chiron's Proleukin recommended for approval for new indication

Dec. 23, 1997

New antitumor agent in development in China

Dec. 22, 1997

Idec's immunotherapy shows promise in phase I/II for non-Hodgkin's lymphoma

Dec. 22, 1997

MAb for non-Hodgkin's lymphoma now available in U.S.

Dec. 19, 1997

Novopharm Biotech's hMAb enters phase I in Canada

Dec. 19, 1997

Seragen reports preliminary results of pivotal CTCL study

Dec. 17, 1997

Phase II results reported for Bexxar

Dec. 15, 1997

Cel-Sci expands Multikine trial

Dec. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...